“showed a trend”

Our study showed a trend of improved 18 F-FDG uptake in the area at risk during 6 months follow-up in the BMC group compared to placebo ( p = 0.07), but FDG-defect size was comparable in the two groups ( p = 0.52).

Major alterations in neuronal discharge activity in GP, STN, and EP in dystonic rats at rest Neuronal discharge rates in dystonic rats were markedly reduced in GP (62%, p < 0.0001) and EP (67%, p < 0.0001) and showed a trend toward a reduction in the STN (33%, p = 0.07).

3 E ), and the combination of MRK003 and gemcitabine showed a trend toward decreased proliferation (P = 0.07; Fig. 3 E ).

Analysis of the data by original therapy assignment showed a trend toward improvement in 4-year DFS after treatment with exemestane compared with placebo (relative risk [RR] = 0.68; P = 0.07).

41 Infants in the Carotenoid Group showed a trend to more advanced EZ grades on average than the Control group ( P = 0.07), suggestive of matured foveal development.

Conversely, the Anyplex TM II HPV28 assay showed a trend toward higher detection of HPV31 (5 cases detected only with the Anyplex TM II HPV28 versus 0 cases detected with the Allplex TM HPV28, p = 0.07) and HPV39 (7 cases detected only with the Anyplex TM II HPV28 versus 1 case detected only with the Allplex TM HPV28, p = 0.08).

Similar to litter mass loss, litter SIR showed a trend for a positive correlation with initial litter DOC in the presence of fauna (r 2 = 0.58, p = 0.07), while soil SIR tended to correlate negatively with initial litter lignin content (r 2 = 0.59, p = 0.07).

A larger ratio of ascending aorta length to diameter ratio in relation to the sheath size corrected by body surface area showed a trend toward developing HITS ( P = .07) ( Table 6 ).

Analysis on the larger clinical sample using all 27 participants also did not show a main effect of Target Type on RT data, F (3, 78) = 1.38, p = 0.26, although the larger analysis showed a trend level effect of sad distracter images on performance, where targets-after-sad had slower response times compared to targets-after-targets, t (26) = 1.89, p = 0.07.

The GCMPS scores showed a trend to decrease between day 3 and day 10 ( p = 0.07).

Also, SM showed a trend to higher IL-7 concentrations compared to their newborns (p = 0.07) (Figure 1 ).

Patients treated with MIT showed a trend towards increased nitrogen balance ( P = 0.070), significantly lower urinary nitrogen excretion ( P = 0.027), and higher serum albumin ( P = 0.047) and prealbumin ( P = 0.001) concentrations than patients treated with CIT.

Trials using more than 500 μg per day of selenium showed a trend towards a lower mortality (RR = 0.80, 95% CI 0.63 to 1.02, P = 0.07) whereas trials using doses lower than 500 μg had no effect on mortality (RR 0.94, 95% CI 0.67 to 1.33, P = 0.75).

Folate by contrast showed a trend for higher values in J haplotype carriers (OR = 1.12; CI 0.99–1.27; p = 0.07).

In the in vitro cell viability assay, anti-miR200b* showed a trend toward enhanced cytotoxicity slightly in cisplatin compared to the negative control (p = 0.07).

However, total CD7 + CD56 + NK cells showed a trend (p = 0.070) toward greater NKp46 density compared to CD7 + CD56 + CD16 + NK cells (Additional file 3 B).

COX-EGFR Regression analysis between COX-1 mRNA and EGFR mRNA showed a trend to significance in tumor tissue (p < 0.07).

At baseline, the mean ABI was higher in the control group ( P = 0.02), and subjects entering the control group showed a trend toward higher scores on avoiding foot-damaging behaviors ( P = 0.07); both these biases would favor better outcomes in the control group.

The 29 grafts (64%) that were postoperatively anticoagulated with warfarin showed a trend toward improved primary patency (47% versus 19%, P =0.07), secondary patency (49% versus 20%, P =0.03), and limb salvage (67% versus 58%, P =0.06), at 3 years.

Pre-specified analysis of HPS2-THRIVE based on sex showed a trend towards worse CV outcomes in women treated with niacin ( p = 0.07).

While HRQoL increased in all patients, obese patients showed a trend towards an even greater improvement of mental HRQoL ( p = 0.07) vs. non- obese patients.

Quality of life, as measured by the PDQUALIF score, showed a trend toward improvement in patients treated with 0.5 mg/day rasagiline ( P = 0.07), but not with 1 mg/day rasagiline.

Only in the univariate analysis, GSTM1 -null patients showed a trend towards an increased incidence of SOS (26% vs. 15%, p = 0.07), diagnosed according to the modified Seattle criteria [ 51 ].

For the milking time, a least-square mean of IL-4 from BM (1571.6 pg/mL) showed a trend in difference from that of BA (2941.9 pg/mL) at p = 0.07 ( Figure 1 (A3)).

In contrast, the distribution of the MYH9 polymorphism in recipients showed a trend toward higher risk of BPAR (31.6% in CC, 32.4% in CA, 39.3% in AA; p = 0.07) ( Fig. 2A ).